InGeneron: InGeneron Shares Results From Phase III Knee Osteoarthritis Study
Data show clinical effectiveness in patients and 'confirms an exceptional safety profile' of the company's cell therapy.
Read full article »
InGeneron develops and commercializes stem cell-based regenerative medicine therapies for the treatment of orthopedic, esthetics and wound care.
Read more